A citation-based method for searching scientific literature

Birgitta Schlüter, Roswitha Gerhards, Dirk Strumberg, Rudolf Voigtmann. J Cancer Res Clin Oncol 2010
Times Cited: 13







List of co-cited articles
80 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
C Bozzetti, F V Negri, C A Lagrasta, P Crafa, C Bassano, I Tamagnini, G Gardini, R Nizzoli, F Leonardi, D Gasparro,[...]. Br J Cancer 2011
104
30

Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.
Spasenija Savic, Noreli Franco, Bruno Grilli, Audrey de Vito Barascud, Michelle Herzog, Beata Bode, Heinz Loosli, Peter Spieler, René Schönegg, Inti Zlobec,[...]. Chest 2010
60
23

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology.
Hatim Husain, David Nykin, Nam Bui, Daniel Quan, German Gomez, Brian Woodward, Sumathi Venkatapathy, Radha Duttagupta, Eric Fung, Scott M Lippman,[...]. Mol Cancer Ther 2017
52
23

Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
Carmen Flores-Staino, Eva Darai-Ramqvist, Katalin Dobra, Anders Hjerpe. Lung Cancer 2010
41
23

The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Esther Diana Rossi, Tommaso Bizzarro, Fernando Schmitt, Adhemar Longatto-Filho. Cancer Cytopathol 2015
21
23

An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting.
K Goto, M Satouchi, G Ishii, K Nishio, K Hagiwara, T Mitsudomi, J Whiteley, E Donald, R McCormack, T Todo. Ann Oncol 2012
87
23

A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer.
Manabu Soda, Kazutoshi Isobe, Akira Inoue, Makoto Maemondo, Satoshi Oizumi, Yuka Fujita, Akihiko Gemma, Yoshihiro Yamashita, Toshihide Ueno, Kengo Takeuchi,[...]. Clin Cancer Res 2012
101
23

EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
Shang-Gin Wu, Yao-Wen Kuo, Yih-Leong Chang, Jin-Yuan Shih, Ya-Hui Chen, Meng-Feng Tsai, Chong-Jen Yu, Chih-Hsin Yang, Pan-Chyr Yang. J Thorac Oncol 2012
78
23

Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.
Tzu-Hsiu Tsai, Shang-Gin Wu, Min-Shu Hsieh, Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih. Lung Cancer 2015
34
23

Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
Fiamma Buttitta, Lara Felicioni, Maela Del Grammastro, Giampaolo Filice, Alessia Di Lorito, Sara Malatesta, Patrizia Viola, Irene Centi, Tommaso D'Antuono, Roberta Zappacosta,[...]. Clin Cancer Res 2013
81
23

Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
Chang Dong Yeo, Jin Woo Kim, Kwan Hyoung Kim, Jick Hwan Ha, Chin Kook Rhee, Seung Joon Kim, Young Kyoon Kim, Chan Kwon Park, Sang Haak Lee, Mi Sun Park,[...]. Lung Cancer 2013
49
23

High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
Ping-Li Sun, Yan Jin, Hyojin Kim, Choon-Taek Lee, Sanghoon Jheon, Jin-Haeng Chung. Cancer Cytopathol 2013
46
23

Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples.
Koji Arihiro, Miyo Oda, Katsunari Ogawa, Kenshi Tominaga, Yoshie Kaneko, Tomomi Shimizu, Shiho Matsumoto, Megumi Oda, Yuki Kurita, Yuko Taira. Jpn J Clin Oncol 2013
11
27


Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
15

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Charles E Geyer, John Forster, Deborah Lindquist, Stephen Chan, C Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman,[...]. N Engl J Med 2006
15

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain.
Brunilde Gril, Diane Palmieri, Julie L Bronder, Jeanne M Herring, Eleazar Vega-Valle, Lionel Feigenbaum, David J Liewehr, Seth M Steinberg, Maria J Merino, Stephen D Rubin,[...]. J Natl Cancer Inst 2008
202
15

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
15

Cell block cytology. Improved preparation and its efficacy in diagnostic cytology.
N A Nathan, E Narayan, M M Smith, M J Horn. Am J Clin Pathol 2000
107
15

HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study.
Elena Verri, Pamela Guglielmini, Matteo Puntoni, Luisa Perdelli, Andrea Papadia, Paola Lorenzi, Alessandra Rubagotti, Nicola Ragni, Francesco Boccardo. Oncology 2005
102
15

Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.
Yunlang Cai, Jingmei Wang, Lin Zhang, Di Wu, Dandan Yu, Xiaoqiang Tian, Jun Liu, Xinru Jiang, Yang Shen, Lihua Zhang,[...]. Med Oncol 2015
54
15

Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Lutfiye Demir, Seyran Yigit, Canan Sadullahoglu, Murat Akyol, Suna Cokmert, Yuksel Kucukzeybek, Ahmet Alacacioglu, Fulya Cakalagaoglu, Mustafa Oktay Tarhan. Asian Pac J Cancer Prev 2014
15
15

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.
Brandon S Sheffield, Harry C Hwang, Anna F Lee, Kim Thompson, Stephanie Rodriguez, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2015
107
15


Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.
Yun Gong, Xiaoping Sun, Claire W Michael, Sam Attal, Beth A Williamson, Carlos W M Bedrossian. Diagn Cytopathol 2003
46
15

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Bryce Noll, Wei-Lien Wang, Yun Gong, Jun Zhao, Neda Kalhor, Victor Prieto, Gregg Staerkel, Sinchita Roy-Chowdhuri. Cancer Cytopathol 2018
74
15

The implementation of liquid-based cytology for lung and pleural-based diseases.
Claire W Michael, Carlos C W M Bedrossian. Acta Cytol 2014
17
15


Diagnostic effects of prolonged storage on fresh effusion samples.
Frances Manosca, Malcolm Schinstine, Patricia A Fetsch, Lynn Sorbara, Anna Maria Wilder, Keith Brosky, Dana Erickson, Mark Raffeld, Armando C Filie, Andrea Abati. Diagn Cytopathol 2007
17
15

BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.
Ann E Walts, Kenzo Hiroshima, Stephanie M McGregor, Di Wu, Aliya N Husain, Alberto M Marchevsky. Diagn Cytopathol 2016
35
15

Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.
Tingting Wang, Xiaoping Qian, Zhongqiu Wang, Lifeng Wang, Lixia Yu, Yitao Ding, Baorui Liu. Int J Cancer 2009
18
15

Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression.
Fauzia Mohamed, Nadine Vincent, Michèle Cottier, Michel Peoc'h, Yacine Merrouche, Brigitte Patouillard, Stéphane Paul, Christian Genin. Biomarkers 2010
5
40


The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Peter B Illei, Marc Ladanyi, Valerie W Rusch, Maureen F Zakowski. Cancer 2003
94
15

Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions.
Ritu Salani, Ben Davidson, Michael Fiegl, Christian Marth, Elisabeth Müller-Holzner, Guenther Gastl, Han-Yao Huang, Jui-Chi Hsiao, Her-Sheng Lin, Tian-Li Wang,[...]. Clin Cancer Res 2007
17
15

Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
Michael Fiegl, Margot Haun, Anita Massoner, Jens Krugmann, Elisabeth Müller-Holzner, Rene Hack, Wolfgang Hilbe, Christian Marth, Hans-Christoph Duba, Günther Gastl,[...]. J Clin Oncol 2004
37
15

Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Shinji Matsumoto, Kazuki Nabeshima, Toshiaki Kamei, Kenzo Hiroshima, Kunimitsu Kawahara, Sakae Hata, Katsuji Marukawa, Yoshihiro Matsuno, Kenichi Taguchi, Tohru Tsujimura. Cancer Cytopathol 2013
38
15

Invited review-next-generation sequencing: a modern tool in cytopathology.
Sinchita Roy-Chowdhuri, Pasquale Pisapia, Manuel Salto-Tellez, Spasenija Savic, Mariantonia Nacchio, Dario de Biase, Giovanni Tallini, Giancarlo Troncone, Fernando Schmitt. Virchows Arch 2019
15
15


EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
Yuri Sheikine, Deepa Rangachari, Danielle C McDonald, Mark S Huberman, Erik S Folch, Paul A VanderLaan, Daniel B Costa. Clin Lung Cancer 2016
33
15

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.
Yi-Lin Chen, Chung-Ta Lee, Cheng-Chan Lu, Shu-Ching Yang, Wan-Li Chen, Yang-Cheng Lee, Chung-Hsien Yang, Shu-Ling Peng, Wu-Chou Su, Nan-Haw Chow,[...]. PLoS One 2016
13
15

Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.
Y Guan, Z J Wang, L Q Wang, D F Hua, J Liu. Genet Mol Res 2016
14
15



EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors.
Jiyoul Yang, Ok-Jun Lee, Seung-Myoung Son, Chang Gok Woo, Yusook Jeong, Yaewon Yang, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han. Cancer Res Treat 2018
17
15


Refractory left pleural effusion in an older patient: Atypical presentation of colorectal carcinoma.
Yujie Yuan, Jinning Ye, Chuangqi Chen, Wu Song, Jianbo Xu, Jianhui Chen, Yaping Xing, Yulong He. Oncol Lett 2015
2
100

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Antonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, Brittany E Harvey, Pamela B Mangu, John M S Bartlett, Michael Bilous, Ian O Ellis, Patrick Fitzgibbons, Wedad Hanna,[...]. Arch Pathol Lab Med 2018
201
15

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
Gillian Ellison, Guanshan Zhu, Alexandros Moulis, Simon Dearden, Georgina Speake, Rose McCormack. J Clin Pathol 2013
206
15

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Harry C Hwang, Brandon S Sheffield, Stephanie Rodriguez, Kim Thompson, Christopher H Tse, Allen M Gown, Andrew Churg. Am J Surg Pathol 2016
96
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.